IL6 and metabolic disease: In addition, given that circulating levels of IL-6 or BCAAs are associated with obesity and diabetes,(Wallenius et al., 2002; Wang et al., 2011) IL-6–mediated BCAA metabolism in skeletal muscle and BAT may also be associated with muscle atrophy in metabolic diseases.